119 filings
Page 2 of 6
8-K
z54relpd hodr
6 Mar 23
Cara Therapeutics Announces Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
ewv9kqnm1aaqf0 kuxal
9 Jan 23
Regulation FD Disclosure
7:00am
8-K
lme5w7564qns5pnaf6r
7 Nov 22
Regulation FD Disclosure
4:47pm
8-K
8pjjh9gc
7 Nov 22
Cara Therapeutics Reports Third Quarter 2022 Financial Results
4:10pm
8-K
v5zoji
3 Nov 22
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
7:12am
8-K
tu1if8 1ks
12 Sep 22
Cara Therapeutics Appoints Ryan Maynard as Chief Financial Officer
6:01am
8-K
7c82w
8 Aug 22
Cara Therapeutics CORPORATE PRESENTATION AUGUST 2022
4:11pm
8-K
69dpez gwmy6
8 Aug 22
Cara Therapeutics Reports Second Quarter 2022 Financial Results
4:11pm
8-K
0tvxhs6g9 vh
30 Jun 22
Regulation FD Disclosure
7:01am
8-K
vrt8qi66f9w 5lt2jum
7 Jun 22
Submission of Matters to a Vote of Security Holders
5:30pm
8-K
vozrb6xcjh10
3 Jun 22
Departure of Directors or Certain Officers
4:30pm
8-K
f0uq0aql8g jbq
9 May 22
Cara Therapeutics Reports First Quarter 2022 Financial Results
4:10pm
8-K
pa225odck 7s93xbewb
11 Mar 22
Cara Therapeutics CORPORATE PRESENTATION MARCH 2022
4:30pm
8-K
mklfqfn2t
1 Mar 22
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
4:10pm
8-K
pwmw1i 7gpswg
10 Jan 22
Results of Operations and Financial Condition
7:00am
8-K
md031 j8d
21 Dec 21
Departure of Directors or Certain Officers
4:30pm
8-K
bepnrl9k5s2tvgt ihp9
20 Dec 21
Cara Therapeutics Announces CMS Grants TDAPA to KORSUVA™ (difelikefalin) Injection
7:00am
8-K
wg5fenf7zox a9opg
8 Nov 21
Cara Therapeutics Reports Third Quarter 2021 Financial Results
4:10pm
8-K
d9dfq4p
3 Nov 21
Cara Therapeutics Announces CEO Transition
8:10am
8-K
qr5rcdmxaf
31 Aug 21
Other Events
12:00am